Defects in the apoptotic and cell death pathways are critical in the survival of glioblastoma and resistance to treatment, and we hypothesized that these defects could be driven by BCL6 activity in glioblastoma, based on the following lines of evidence. The gene discussed is BCL6; the disease is glioblastoma.